The NHS Bowel Cancer Screening Program: current perspectives on strategies for improvement
Authors:
Open Access
- 1 December 2017
- journal article
- review article
- Published by Taylor & Francis in Risk Management and Healthcare Policy
- Vol. ume 10, 177-187
Abstract
Colorectal cancer (CRC) is the third most common cancer in the UK. The English National Health Service (NHS) Bowel Cancer Screening Program (BCSP) was introduced in 2006 to improve CRC mortality by earlier detection of CRC. It is now offered to patients aged 60–74 years and involves a home-based guaiac fecal occult blood test (gFOBt) biennially, and if positive, patients are offered a colonoscopy. This has been associated with a 15% reduction in mortality. In 2013, an additional arm to BCSP was introduced, Bowelscope. This offers patients aged 55 years a one-off flexible sigmoidoscopy, and if several adenomas are found, the patients are offered a completion colonoscopy. BCSP has been associated with a significant stage shift in CRC diagnosis; however, the uptake of bowel cancer screening remains lower than that for other screening programs. Further work is required to understand the reasons for nonparticipation of patients to ensure optimal uptake. A change of gFOBt kit to the fecal immunochemical tests (FIT) in the English BCSP may further increase patient participation. This, in addition to increased yield of neoplasia and cancers with the FIT kit, is likely to further improve CRC outcomes in the screened population.Keywords
This publication has 55 references indexed in Scilit:
- UK key performance indicators and quality assurance standards for colonoscopyGut, 2016
- A lack of information engagement among colorectal cancer screening non-attenders: cross-sectional surveyBMC Public Health, 2016
- Uptake of Bowel Scope (Flexible Sigmoidoscopy) Screening in the English National Programme: the first 14 monthsJournal of Medical Screening, 2015
- The impact of hyoscine-N-butylbromide on adenoma detection during colonoscopy: meta-analysis of randomized, controlled studiesGastrointestinal Endoscopy, 2014
- Optimising faecal occult blood screening:retrospective analysis of NHS Bowel Cancer Screening data to improve the screening algorithmBritish Journal of Cancer, 2014
- Computed tomographic colonography versus colonoscopy for investigation of patients with symptoms suggestive of colorectal cancer (SIGGAR): a multicentre randomised trialThe Lancet, 2013
- Bowel cancer screening is safe, detects earlier stage cancer and adenomas in 50% of cases: experience of the prevalent round of screening from two first wave centres in the North East of EnglandFrontline Gastroenterology, 2011
- Colonoscopy quality measures: experience from the NHS Bowel Cancer Screening ProgrammeGut, 2011
- Colorectal Cancer: CT Colonography and Colonoscopy for Detection—Systematic Review and Meta-AnalysisRadiology, 2011
- Randomised controlled trial of faecal-occult-blood screening for colorectal cancerThe Lancet, 1996